(Q51483188)
Statements
1 reference
A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes. (English)
1 reference
Markolf Hanefeld
1 reference
Rita Patwardhan
1 reference
Nigel P Jones
1 reference
Rosiglitazone Clinical Trials Study Group
1 reference
20 March 2006
1 reference
17
1 reference
1
1 reference
13-23
1 reference
Identifiers
1 reference